Canopy Growth Co. (TSE:WEED) had its target price upped by equities research analysts at Eight Capital from C$18.00 to C$22.00 in a report released on Monday. Eight Capital’s price target suggests a potential upside of 15.55% from the stock’s previous close.

A number of other analysts also recently commented on WEED. Canaccord Genuity reiterated a “buy” rating and set a C$9.50 target price on shares of Canopy Growth in a research report on Tuesday, August 15th. Beacon Securities downgraded Canopy Growth from a “buy” rating to a “hold” rating and set a C$16.50 target price on the stock. in a research report on Monday, November 13th.

Canopy Growth (WEED) traded up C$0.09 on Monday, reaching C$19.04. The company’s stock had a trading volume of 2,487,292 shares, compared to its average volume of 2,679,792. Canopy Growth has a one year low of C$6.58 and a one year high of C$21.72.

ILLEGAL ACTIVITY WARNING: This story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/11/27/canopy-growth-co-weed-pt-raised-to-c22-00-at-eight-capital.html.

About Canopy Growth

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc and changed its name to Canopy Growth Corporation in September 2015.

Receive News & Ratings for Canopy Growth Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth Co. and related companies with MarketBeat.com's FREE daily email newsletter.